US export controls achieving no strategic gain but hurting American firms, survey finds
A recent flash survey by the US-China Business Council (USCBC) found that the Trump administration's export-control licensing regime is yielding minimal strategic benefits for the United States. Conducted in July, the survey revealed that months-long delays in processing export licenses are costing the U.S.
Briefing Summary
AI-generatedA recent flash survey by the US-China Business Council (USCBC) found that the Trump administration's export-control licensing regime is yielding minimal strategic benefits for the United States. Conducted in July, the survey revealed that months-long delays in processing export licenses are costing the U.S. billions in lost exports and diminishing American companies' global market share. A significant portion of these pending licenses are for items readily available in China from local or international suppliers, suggesting these controls are not achieving strategic gains. The survey highlights that these delays are effectively sidelining American businesses without a clear strategic advantage.
Article analysis
Model · rule-basedKey claims
5 extractedThe regime is undermining American companies’ global market share.
The export-control licensing regime is costing the US billions of dollars in lost exports.
US export controls are achieving little strategic benefit.
This effectively sidelines American companies for no strategic gain.
Most pending export licenses are for items already available in China from Chinese or international suppliers.